Head-to-head · WeighScore
Pomegranate Health vs Vytora Health
The verdict
Vytora Health takes it — 72.3/100 to 69.4/100.
Vytora Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Vytora Health is a 50-state-plus-DC telehealth platform offering compounded semaglutide and tirzepatide alongside brand-name Mounjaro and Zepbound, plus NAD+ and sermorelin peptides.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Pomegranate Health | Vytora Health |
|---|---|---|
| WeighScore | 69.4/100 | 72.3/100 |
| Grade | C | C |
| Scorecard rank | #122 | #79 |
| Semaglutide | $119/mo (starting price, compounded) | $180/mo (all doses, compounded) |
| Tirzepatide | $149/mo (Starter tier, compounded) | $249/mo (all doses, compounded) |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #122 · C
Strengths
- No membership and no consultation fee — the site states 'No Membership required' and 'Transparent pricing, no hidden fees'
- The semaglutide price sits in the product page's own static HTML, so it can be read before any intake
- Shipping is included: 'shipped discreetly to your door at no extra cost'
- Both semaglutide and tirzepatide are offered
Where it loses points
- The tirzepatide price is not on the public site at all — it exists only inside the in-app pricing portal, and there is no standalone tirzepatide product page to read it from
- Both published figures are floors, a 'Starts @' and a Starter tier, and no price is published for the dose you titrate up to
- The states it can prescribe in are not disclosed anywhere; the dataset's own note records that semaglutide was unavailable in CA, IA and WI
- Klarna, Afterpay and Affirm are offered at checkout, so any monthly figure seen in a financing widget is an instalment and not the medication price
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Graded #79 · C
Strengths
- All 50 states plus DC, with per-state video-vs-audio compliance disclosed
- Both compounded and brand-name options on one platform — uncommon
- LegitScript Approved and HIPAA compliant
- Pharmacy partners named publicly: Vials Pharmacy (TX) and Greenwich Biosciences
- Operating entity disclosed: Wasef Health, PC (Pinellas Park, FL)
Where it loses points
- Brand-name Mounjaro/Zepbound at $1,399/mo is near retail — insured patients may do better via LillyDirect Self Pay ($449-$699/mo)
- Compounded tirzepatide at $249/mo is mid-market, above the $149-199 floor
- Dose tiers aren't broken out — 'all doses included' means low-dose patients pay the same as high-dose
- Initial consultation cost not shown on the public pricing page
- Limited per-prescriber state licensure detail
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.